Phase II trial of weekly 24-hour infusion of gemcitabine in patients with advanced gallbladder and biliary tract carcinoma. [electronic resource]
Producer: 20060327Description: 61 p. digitalISSN:- 1471-2407
- Adenocarcinoma -- metabolism
- Adult
- Aged
- Aged, 80 and over
- Antimetabolites, Antineoplastic -- administration & dosage
- Biliary Tract Neoplasms -- drug therapy
- Carcinoma -- drug therapy
- Deoxycytidine -- administration & dosage
- Disease Progression
- Disease-Free Survival
- Dose-Response Relationship, Drug
- Female
- Gallbladder Neoplasms -- drug therapy
- Humans
- Male
- Middle Aged
- Models, Statistical
- Time Factors
- Tomography, X-Ray Computed
- Treatment Outcome
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.